Skip to content

Effect of Mentor Support for improvement of social participation of adolescents with visual impairments

Effectiveness of Mentor Support for the improvement of social participation of adolescents with visual impairments: a Dutch randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22616
Enrollment
120
Registered
2014-09-04
Start date
2014-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body functions and Structures: Visual impairment and blindness are defined conform criteria of the World Health Organization (WHO): Visual impairment is defined as the best corrected visual acuity in the better eye of < 0.3 but &#8805

Interventions

Mentor Support is an intervention developed for adolescents with problems with social participation. These adolescents have a visual impairment but no additional impairments, such as a hearing or inte

Sponsors

VU University Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosed with visual impairment – Age between 16 and 22 years – Living in the Netherlands

Exclusion criteria

Exclusion criteria: - No additional impairments, such as hearing or intellectual impairments - Not speaking and understanding the Dutch language

Design outcomes

Primary

MeasureTime frame
Primary outcome measures are the effectiveness of Mentor Support and the improvement of social participation in adolescents with visual impairments.

Secondary

MeasureTime frame
Secondary outcome measures are to map the indicators of psychosocial factors of adolescents with visual impairment, to investigate the pathways and milestones to (successful) social participation and to evaluate the experiences of adolescents with visual impairments during Mentor Support.

Contacts

Public ContactE.C.M. Heppe
e.c.m.heppe@vu.nl020-598 9276

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)